From Wikipedia, the free encyclopedia
Major histocompatibility complex, class II, DQ beta
1, also known as HLA-DQB1, is a human gene and also denotes the genetic locus which
contains this gene.[1]
The protein encoded by this
gene is one of two proteins that are required to form the DQ heterodimer, a cell surface receptor
essential to the function of the immune system.
Function
HLA-DQB1 belongs to the HLA class II beta chain paralogues. This class II molecule
is a heterodimer consisting of an alpha (DQA) and a beta chain
(DQB), both anchored in the membrane. It plays a central role in
the immune system by presenting peptides derived from extracellular
proteins. Class II molecules are expressed in antigen-presenting cells (APC: B
lymphocytes, dendritic cells, macrophages).[1]
Gene structure and
polymorphisms
The beta chain is approximately 26-28 kDa and it contains 5 exons. Exon one encodes the leader
peptide, exons 2 and 3 encode the two extracellular protein domains,
exon 4 encodes the transmembrane domain and exon 5
encodes the cytoplasmic
tail. Within the DQ molecule both the alpha chain and the beta
chain contain the polymorphisms specifying the
peptide binding specificities, resulting in up to 4 different
molecules. Typing for these polymorphisms is routinely done for bone marrow
transplantation.[1][2]
Disease
association
Diabetes
Several alleles of HLA-DQB1
are associated with an increased risk of developing type 1 diabetes.[3][4][5]
The locus also has the genetic name IDDM1 as it is the highest
genetic risk for type 1 diabetes. Again the DQB1*0201 and DQB1*0302
alleles, particularly the phenotype DQB1*0201/*0302 has a high risk
of late onset type 1 diabetes. The risk is partially shared with
the HLA-DR locus (DR3 and DR4 serotypes).
Coeliac
disease
Celiac1 is a genetic name for DQB1, the HLA DQB1*0201, *0202,
and *0302 encode genes that mediate the autoimmune coeliac
disease. Homozygotes of DQB1*0201 have a higher risk of
developing the coeliac disease, relative to any other genetic
locus.[6]
Multiple
sclerosis
Certain HLA-DQB1 alleles are also linked to a modest increased
risk of multiple sclerosis.[7][8]
Narcolepsy
Other HLA-DQB1 alleles are associated with a predisposition to
narcolepsy.[9]
Alleles
See also
References
- ^ a
b
c
"Entrez Gene: HLA-DQB1 major
histocompatibility complex, class II, DQ beta 1". http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3119.
- ^ Lau M, Terasaki PI, Park MS (1994).
"International Cell Exchange, 1994". Clin Transpl: 467–88.
PMID 7547576.
- ^ Todd JA (April 1990). "Genetic control of
autoimmunity in type 1 diabetes". Immunol. Today
11 (4): 122–9. doi:10.1016/0167-5699(90)90049-F. PMID 2187469.
- ^ Todd JA (March 1997). "Genetics of type 1
diabetes". Pathol. Biol. 45 (3): 219–27.
PMID 9296067.
- ^ Redondo MJ, Fain PR, Eisenbarth GS (2001).
"Genetics of type 1A diabetes". Recent Prog. Horm. Res.
56: 69–89. doi:10.1210/rp.56.1.69. PMID 11237226.
- ^ Murray JA, Moore SB, Van Dyke CT, et
al. (December 2007). "HLA DQ gene dosage and risk and severity
of celiac disease". Clin. Gastroenterol. Hepatol.
5 (12): 1406–12. doi:10.1016/j.cgh.2007.08.013. PMID 17919990.
- ^ Dyment DA, Sadovnick AD, Ebers GC,
Sadnovich AD (1997). "Genetics of multiple sclerosis". Hum.
Mol. Genet. 6 (10): 1693–8. doi:10.1093/hmg/6.10.1693. PMID 9300661.
- ^ Schmidt H, Williamson D, Ashley-Koch A
(May 2007). "HLA-DR15 haplotype and multiple sclerosis: a HuGE
review". Am. J. Epidemiol. 165 (10):
1097–109. doi:10.1093/aje/kwk118.
PMID 17329717.
- ^ Kadotani H, Faraco J, Mignot E (May 1998).
"Genetic studies in the sleep disorder narcolepsy". Genome
Res. 8 (5): 427–34. doi:10.1101/gr.8.5.427. PMID 9582188.
|
Surface antigens |
|
Major histocompatibility
complex/
Human leukocyte antigen |
|
|
|
|
|
|
HLA-DM ( α, β) • HLA-DO ( α, β) • HLA-DP ( α1, β1) • HLA-DQ ( α1, α2, β1, β2, β3) • HLA-DR ( α, β1,
β3, β4, β5)
Minor histocompatibility
antigen
|
|
|
|
Other |
|
|
|
PDB Gallery |
|
|
|
|
1jk8: Crystal structure of a human insulin
peptide-HLA-DQ8 complex
|
|
|
|
1s9v: Crystal structure of HLA-DQ2 complexed with
deamidated gliadin peptide
|
|
|
|